DAMORA THERAPEUTICS, INC. Income Taxes Paid
DAMORA THERAPEUTICS, INC. (DMRA) reported Income Taxes Paid of $5.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-08-10
- DAMORA THERAPEUTICS, INC. income taxes paid, net for the quarter ending 2025-12-31 was $0.00.
- DAMORA THERAPEUTICS, INC. income taxes paid, net for the quarter ending 2025-09-30 was $0.00.
- DAMORA THERAPEUTICS, INC. income taxes paid, net for the quarter ending 2025-06-30 was $3.00K.
- DAMORA THERAPEUTICS, INC. income taxes paid, net for the quarter ending 2025-03-31 was $2.00K.
- DAMORA THERAPEUTICS, INC. income taxes paid, net for fiscal 2025 was $5.00K.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.00K 10-Q · filed 2026-08-10 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $0.00 derived: sum of 2 quarters · filed 2026-03-19 | $3.00K derived: sum of 3 quarters · filed 2026-08-10 | $5.00K 10-K · filed 2026-03-19 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $3.00K derived: sum of 2 quarters · filed 2026-08-10 | $5.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $5.00K 10-Q · filed 2026-08-10 | ||
| 2025-03-31 | $2.00K 10-Q · filed 2026-05-12 | |||
| 2021-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $2.00K derived: sum of 2 quarters · filed 2022-11-08 | $40.00K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | $42.00K 10-Q · filed 2022-07-29 | ||
| 2021-03-31 | $38.00K 10-Q · filed 2022-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |